Evidence map›Paper›PMID 27576735›Full record

ArticleLipids in health and disease2016

A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.

Pu-Hong Zhang, Jia-Lin Gao, Chun Pu, Gang Feng, Li-Zhuo Wang, Li-Zhu Huang, Yao Zhang

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Apolipoprotein M gene polymorphisms in childhood-onset type 1 diabetes in southern Brazil.International journal of biochemistry and molecular biology · 2023
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pu-Hong ZhangAnhui Province Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, People's Republic of China.
Jia-Lin GaoAnhui Province Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, People's Republic of China.
Chun PuDepartment of Clinical Laboratory, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.
Gang FengDepartment of Clinical Laboratory, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.
Li-Zhuo WangDepartment of Biochemistry and Molecular Biology, Wannan Medical College, 22 West Wenchang Road, Wuhu, 241002, People's Republic of China.
Li-Zhu HuangDepartment of Clinical Laboratory, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.
Yao ZhangDepartment of Biochemistry and Molecular Biology, Wannan Medical College, 22 West Wenchang Road, Wuhu, 241002, People's Republic of China. yaozhang_wnmc@yahoo.com.
Wannan Medical College · CNFirst Affiliated Hospital of Wannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApolipoprotein M (apoM) was the carrier of the biologically active lipid mediator sphingosine-1-phospate in high density lipoprotein cholesterol (HDL-C) and played a critical role in formation and maturation of prebeta-HDL-C particles. The plasma apoM levels were decreased obviously in patients with type 2 diabetes mellitus (T2DM). A new single-nucleotide polymorphism (SNP) C-724del in apoM promoter was associated with a higher risk for coronary artery diseases (CAD) and myocardial infarction, could reduce promoter activities and apoM expression in vitro. The primary aim of the present case-controls study was to investigate the effect of apoM SNP C-724del on apoM expression in vivo and its association with T2DM susceptibility in an eastern Han Chinese cohort.

methodsTwo hundred and fifty-nine T2DM patients and seventy-six healthy controls were included in this study. Amplifying DNA of apoM proximal promoter region including SNP C-724del by Real-Time Polymerase Chain Reaction (RT-PCR) and amplicons sequencing. The plasma apoM concentrations were assayed by enzyme linked immunosorbentassay (ELISA).

resultsFour polymorphic sites, rs805297 (C-1065A), rs9404941 (T-855C), rs805296 (T-778C), C-724del were confirmed. rs805297 (C-1065A) and rs9404941 (T-855C) showed no statistical difference in allele frequencies and genotype distributions between T2DM patients and healthy controls just as previous studies. It's worth noting that the difference of rs805296 (T-778C) between these two groups was not found in this study. In SNP C-724del, the frequency of del allele and mutant genotypes (del/del, C/del) were higher in T2DM patients compared with healthy controls (p = 0.035; P = 0.040, respectively), while the plasma apoM levels of C-724del mutant allele carriers compared with the wide-type homozygotes carriers were not statistically different in T2DM patients (18.20 ± 8.53 ng/uL vs 20.44 ± 10.21 ng/uL, P = 0.245).

conclusionThe polymorphism C-724del in the promoter region of the apoM gene could confer the risk of T2DM among eastern Han Chinese. Unfortunately, the lowing of plasma apoM levels of C-724del mutant allele carriers compared with the wide-type homozygotes carriers in T2DM patients was not statistically different in present study, so further researchs were needed by enlarging the sample.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAdultAgedApolipoproteinsApolipoproteins MDiabetes Mellitus, Type 2FemaleGenotypeHumansLipocalinsMaleMiddle AgedPolymorphism, Single NucleotideRiskSequence DeletionApolipoproteinsApolipoproteins MAPOM protein, humanLipocalinsApolipoproteinsDiabetesSingle-nucleotide polymorphism

Identifiers

PMID27576735
PMCPMC5006532
OpenAlexW2514988862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.